It has not been confirmed that ropinirole is safe and effective for use in people younger than 18 years.
In vitro metabolism studies showed that CYP1A2 is the major enzyme responsible for the metabolism of Ropinirole.
You should not be taking more than 1 medicine containing Ropinirole.
REQUIP can decrease or increase your heart rate. The dose may be increased to 1. There is not enough information to tell whether medications used to treat Parkinson s disease such as ropinirole increase the risk of developing skin cancer. Some patients taking REQUIP or REQUIP XL get urges to behave in a way unusual for them.
If you have hallucinations or any of these other psychotic-like changes, talk with your healthcare provider. Ask your pharmacist about the safe use of those products.
Ask your doctor before use if you are taking the following medications:
For the reasons stated above, patients and providers are advised to monitor for melanomas frequently and on a regular basis when using Parlodel for any indication.
When a person takes large doses of drugs that interact with serotonin, it can lead to too much of the neurotransmitter accumulating in the brain.
If coadministration is considered necessary by the practitioner, and the patient has known risk factors for cardiac disease or arrhythmia, then close monitoring is essential.
Avoid drinking alcohol, which can increase some of the side effects of ropinirole. This restriction typically requires that certain criteria be met prior to approval for the prescription. Your doctor may have suggested this medication for conditions other than those listed in these drug information articles. How to tell if the drug is working.